Earnings Feed
Sign Up
Home/Insiders/LAVIGNE LOUIS J JR
LL
SEC Insider//CIK 0001214127

LAVIGNE LOUIS J JR

CIK 00012141274 companiesSAN DIEGO, CA
SEC Profile

Transactions

50

Companies

4

Filings

6

CIK

0001214127

Recent Transactions

50 trades
  • Award
    ARENA PHARMACEUTICALS INC

    Employee Stock Option (right to buy)

    2006-07-28+10,000→ 10,000 total
  • Award
    ARENA PHARMACEUTICALS INC

    Employee Stock Option (right to buy)

    2006-07-28+10,000→ 10,000 total
  • Award
    KYPHON INC

    Director Stock Option (Right to Buy)

    2005-07-01+7,500→ 27,500 total
  • Award
    KYPHON INC

    Director Stock Option (Right to Buy)

    2005-07-01+7,500→ 27,500 total
  • Award
    ARENA PHARMACEUTICALS INC

    Employee Stock Option (right to buy)

    2005-01-17+25,000→ 25,000 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-12-02$12.13/sh+25,000→ 25,000 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-12-02$50.91/sh−25,000→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-12-02−50,000→ 300,000 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-12-02$50.91/sh−25,000→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-12-02−25,000→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-12-02$50.91/sh−50,000→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-12-02−25,000→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-12-02$50.91/sh−50,000→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-12-02$14.28/sh+50,000→ 50,000 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-12-02−50,000→ 300,000 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-12-02$14.28/sh+50,000→ 50,000 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-12-02$12.13/sh+25,000→ 25,000 total
  • Award
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-09-23+200,000→ 200,000 total
  • Award
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-09-23+200,000→ 200,000 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.06/sh−100→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+100→ 100 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.02/sh−4,300→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−2,800→ 360,200 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.05/sh−700→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−3,700→ 365,700 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−10,800→ 268,700 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−2,000→ 250,000 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+1,200→ 1,200 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.11/sh−400→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+1,900→ 1,900 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+1,300→ 1,300 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+700→ 700 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+4,300→ 4,300 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.00/sh−8,900→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.53/sh−600→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.23/sh−2,000→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.04/sh−4,100→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.17/sh−200→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.16/sh−1,900→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−1,400→ 291,800 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−4,900→ 313,100 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.24/sh−23,500→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.30/sh−4,600→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+200→ 200 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+300→ 300 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−200→ 363,600 total
  • Exercise/Conversion
    GENENTECH INC

    Non-Qualified Stock Option (right to buy)

    2004-01-23−600→ 280,800 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.10/sh−1,200→ 0 total
  • Sale
    GENENTECH INC

    Common Stock

    2004-01-23$96.15/sh−3,700→ 0 total
  • Exercise/Conversion
    GENENTECH INC

    Common Stock

    2004-01-23$24.25/sh+800→ 800 total

Companies

4

Recent Filings

6

Address

C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE

SAN DIEGO, CA, 92121

View on SEC.gov